• OPEN AN ACCOUNT
Indian Indices
Nifty
25,517.05 -120.75
(-0.47%)
Sensex
83,693.28 86.82
( 0.10%)
Bank Nifty
57,312.75 -131.15
( -0.23%)
Nifty IT
38,950.00 127.05
( 0.33%)
Global Indices
Nasdaq
44,111.35 271.07
(0.62%)
Dow Jones
6,226.00 31.93
(0.52%)
Hang Seng
40,353.62 202.83
(0.51%)
Nikkei 225
8,760.96 -37.95
(-0.43%)
Forex
USD-INR
85.41 -0.32
(-0.37%)
EUR-INR
100.07 -0.25
(-0.25%)
GBP-INR
117.16 -0.49
(-0.42%)
JPY-INR
0.59 0.00
(-0.52%)

EQUITY - MARKET SCREENER

IVRCL Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
530773
INE875A01025
-229.621835
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IVRCLINFRA
0
30.53
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

norben tea & exports ltd
Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter
May 23,2025
Net loss of Shree Ganesh Biotech India reported to Rs 0.95 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales declined 20.37% to Rs 3.01 crore in the quarter ended March 2025 as against Rs 3.78 crore during the previous quarter ended March 2024.

For the full year,net profit declined 54.84% to Rs 0.28 crore in the year ended March 2025 as against Rs 0.62 crore during the previous year ended March 2024. Sales rose 13.21% to Rs 22.96 crore in the year ended March 2025 as against Rs 20.28 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales3.013.78 -20 22.9620.28 13
OPM %-47.18-13.76 --4.57-1.04 -
PBDT-0.950.54 PL 0.390.85 -54
PBT-0.950.54 PL 0.390.85 -54
NP-0.950.54 PL 0.280.62 -55